Clinical trial design confirmed during FDA Type C meeting held on January 3, 2018 Simplified patient entry criteria to include IPF patients whether on background standard of care (i.e. nintedanib) or not Primary endpoint ...
Annual tobacco report assigns grades to state and federal government efforts to implement proven tobacco control policies, save lives CHICAGO , Jan. 24, 2018 /PRNewswire-USNewswire/ -- The American Lung Association's 16 th annual "State ...
MENLO PARK, Calif. , Jan. 8, 2018 /PRNewswire/ -- NuMedii, Inc. today announced the formation of an Idiopathic Pulmonary Fibrosis (IPF) Advisory Board consisting of the world's leading experts in interstitial lung disease: Naftali Kaminski , ...
LONDON , Jan. 8, 2018 /PRNewswire/ -- Venous Thromboembolism (VTE) is a lethal disorder that affects the hospitalized and non-hospitalized patients, recurs frequently, and results in long-term complications including chronic thromboembolic ...
Mycoplasma and Virus to be the Leading Causative Agents in the Global Swine Respiratory Diseases Treatment Market VALLEY COTTAGE, New York , December 7, 2017 /PRNewswire/ -- Swine respiratory diseases treatment is carried out by drugs ...
NEW YORK , Dec. 5, 2017 /PRNewswire/ -- Converging technologies are creating new ways for patients diagnosed with chronic upper respiratory illnesses to improve outcomes while avoiding external factors that may exacerbate or trigger their ...
NEW YORK , Dec. 5, 2017 /PRNewswire/ -- Future Market Insights offers 10-year forecast on the global respiratory inhaler devices market between 2017 and 2027. This study covers the market dynamics and trends in major countries that are ...
NEW YORK , Dec. 4, 2017 /PRNewswire/ -- The lung stents market is expected to reach USD 105.6 million by 2022 from an estimated USD 76.3 million in 2017, at a CAGR of 6.7% from 2017 to 2022. The rapidly increasing geriatric population, ...
LONDON , Nov. 28, 2017 /PRNewswire/ -- How well does your asthma/COPD medical affairs team performance compare with the rest? According to this latest survey of 150 pulmonologists and primary care physicians across the EU5 (UK, France , ...
LONDON , Nov. 28, 2017 /PRNewswire/ -- How well does your asthma/COPD medical affairs team performance compare with the rest? Download the full report: https:www.reportbuyer.com/product/5214591 According to this latest survey of 100 US ...
New research being presented at this year's ESCMID Global Congress in Barcelona, Spain (27-30 April) suggests that tuberculosis (TB) can have long-term effects on the lungs of individuals who have been successfully treated for the ...
A SARS-CoV-2 infection does not significantly heighten the risk of asthma development in pediatric patients, stated study published in the journal Pediatrics ( ). Respiratory viral infections early in life are risk factors for asthma. ...
Clinical trial data submissions to the Food and Drug Administration (FDA) for Sanofi/Regeneron’s Dupixent and Verona’s Ensifentrine herald the introduction of novel therapies for chronic obstructive pulmonary disease (COPD) in 2024. Both ...
Experts emphasized that although coughing ( ) is a prominent symptom of tuberculosis (TB), it's crucial for people to understand that many cases can present without this indicator. ...
Dr. Kuldeep Singh Sachdeva, previously leading India’s TB elimination program at the Ministry of Health and Family Welfare, highlighted that unreported Tuberculosis (TB) cases and delays in diagnosis and treatment pose significant challenges to ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers